As a result, the purpose of this study was to see whether c-Met CAR-T successfully suppressed A549 cells growth and promoted apoptosis, and to see whether CAR-T therapy targeting c-Met might be used to treat NSCLC. The gene discussed is MET; the disease is non-small cell lung carcinoma.